IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis.
Journal: Journal Of Neuroimmunology
Published:
Abstract
Recent studies have revealed an association between interleukin 28B (IL28B) and response to IFN-alpha treatment in hepatitis C patients. Here we investigated the influence of IL28B polymorphisms in the response to interferon-beta (IFNβ) in multiple sclerosis (MS) patients. We genotyped two SNPs of the IL28B gene (rs8099917 and rs12979860) in 588 MS patients classified into responders (n=281) and non-responders (n=307) to IFNβ. Combined analysis of the study cohorts showed no significant associations between SNPs rs8099917 and rs12979860 and the response to treatment. These findings do not support a role of IL28B polymorphisms in the response to IFNβ in MS patients.
Authors
S Malhotra, C Morcillo Suárez, D Brassat, R Goertsches, J Lechner Scott, E Urcelay, O Fernández, J Drulovic, A García Merino, F Martinelli Boneschi, A Chan, K Vandenbroeck, A Navarro, M Bustamante, J Río, D Akkad, G Giacalone, A Sánchez, L Leyva, R Alvarez Lafuente, U Zettl, J Oksenberg, X Montalban, M Comabella
Relevant Conditions